Study Title: A Phase III Randomized Trial of Steroids + Tyrosine Kinase Inhibitor (TKI) Induction with Chemotherapy or Blinatumomab for Newly Diagnosed BCR ABL positive Acute Lymphoblastic Leukemia (ALL) in Adult
For more information about the trial above please contact the study team:Medical University of South CarolinaPrincipal Investigator, Baratam, Praneeth, at baratamp@musc.edu.Study Coordinator, Baker, Hana, at bakerhan@musc.edu.Trial opened at the following institutions: Medical University of South Carolina